Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
Efficiency and Tolerability of Induction and Consolidation Therapy with Arsenic Trioxide/Bortezomib/Ascorbic Acid/Dexamethasone (ABCD) Regimen Compared to Bortezomib/Dexamethasone (BD) Regimen in Newly Diagnosed Myeloma Patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,609 | Dovepress* | 7,225+ | 946 | 8,171 | |
| PubMed Central* | 384 | 143 | 527 | ||
| Totals | 7,609 | 1,089 | 8,698 | ||
| *Since 20 January 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar